Table 4.
Treatment | Immune cells | M1-like TAMs | M2-like TAMs | VEGF |
---|---|---|---|---|
Control | 6.83 | 0.073 | 0.383 | 0.34 |
CRLX101 (with normalization) | 17.65 | 0.234 | 0.081 | 0.12 |
CRLX101(without normalization) | 10.18 | 0.141 | 0.154 | 0.21 |
Treatment | Immune cells | M1-like TAMs | M2-like TAMs | VEGF |
---|---|---|---|---|
Control | 6.83 | 0.073 | 0.383 | 0.34 |
CRLX101 (with normalization) | 17.65 | 0.234 | 0.081 | 0.12 |
CRLX101(without normalization) | 10.18 | 0.141 | 0.154 | 0.21 |